Citation Tools

Download PDFPDF
Systematic review
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

Download to a citation manager

Cite this article as:
Tenenbaum A, Fisman EZ
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality